Next Generation Sequencing Market is Expected to Reach USD 22.16 billion By 2027 at a CAGR of 15.9 % | Reports and Data

According to the current analysis of Reports and Data, the global next generation sequencing market was valued at USD 5,793.4 million in 2019 and is expected to reach USD 22.16 billion by the year 2027, at a CAGR of 15.9%. Next-generation sequencing non-Sanger based high throughput method of sequencing. Entire next generation sequencing methodology engages a wide range of reagents, kits, equipment, software and tools for the pieces of its entire workflow that includes sample preparation, library preparation & amplification, sequencing, and analysis. Due to the constant innovations in the NGS technologies, there has been a significant decline in the sequencing costs, complexity and turnaround time. Horizons of the NGS applications is expanding, which in turn offers ample opportunities to emerging as well the existing market players.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.reportsanddata.com/sample-enquiry-form/1868

Illumina, ThermoFisher Scientific, Pacific biosciences, and Oxford Nanopore Technologies are among key innovators of next generation sequencing technologies. Based on the application, individual technologies are conquering the NGS markets across the globe. Illumina's SBS technology remains the top choice of the researchers across the globe, considering the reducing costs and high precision. Clinical Diagnostic applications of NGS is dominated by ThermoFisher's semiconductor NGS technology owing it to its less turnaround time. Pacific Biosciences' long read sequencing technology is paving its success path for the de-novo sequencing applications. Oxford Nanopore remains a key innovator with its long read, portable, real-time sequencing offerings. Despite differences in the technological basis of individual companies, the market players in NGS products & services are focused on providing low cost, efficient, reliable, user friendly, compact and accurate sequencing experience to their customers. Furthermore, bioinformatics tools plays a vital role in the advancement of NGS workflow and analysis, and continues to register significant growth in the global market. Also, NGS services holds more than one fourth of the revenue generated in the global next generation sequencing market and is fragmented in nature, unlike NGS products market.

Furthermore, increased government initiatives, availability of research funds from private as well as public bodies, improvement in the reimbursement scenario for NGS based diagnostics, and rising awareness about benefits of NGS technologies are among the key factors propelling the growth of next generation sequencing market.

Further key findings from the report suggest:

NGS platforms segment is expected to grow with a CAGR of 14.7% during the forecast period. Consumables remains the chief revenue generating segment in global next generation sequencing market

Diagnosis of complex diseases, whole-genome sequencing, analysis of epigenetic modifications, mitochondrial sequencing, transcriptome sequencing, and exome sequencing, are among the key applications of NGS contributing to the market growth

The volume of data generated from sequencing has significantly increased as a result of wide scale use of next generation sequencing. Consequently, the demand for NGS data analysis & data management tools & software is on surge
RNA-Seq through next generation sequencing allows profiling of the entire transcriptome, including the coding and non-coding regions; and facilitates gene identification, provides information on their relative abundance, identification of novel transcripts, detection of other genetic variation

Reduced costs and increased reliability of underlying NGS technologies has allowed next generation sequencing to flourish for research applications as well as healthcare applications such as clinical development, and clinical diagnostics

North America remains the key revenue generating geographical segment in next generation sequencing market. The geographical segment accounted for USD 1.88 billion in 2019. Availability of research funds from public as well as private sources, availability of state-of-art technologies, presence of key market players in the region, favorable reimbursements for NGS based diagnostics, rising focus on precision medicine, and rising awareness about NGS applications, are among the key factors driving the market growth for next generation sequencing in this region

Competitive Landscape:

The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, product & service portfolio. The Next Generation Sequencing market is extremely competitive and consists of several key players at regional and global level. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures and collaborations to strengthen their market position and enhance product portfolio.

Leading companies operating in the market are:

Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Oxford Nanopore Technologies, Ltd. (U.K.), BGI (China), PerkinElmer (U.S.), Agilent Technologies (U.S.), QIAGEN N. V. (Germany), Macrogen Inc. (South Korea), and Eurofins Scientific (Luxembourg)

Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/1868

The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:

Next Generation Sequencing Market Segmentation:

Product & Service Outlook (Revenue in Million USD; 2017-2027)

Pre-sequencing Products and Services
NGS Consumables
NGS Platforms
Services for NGS Platforms
Sequencing Services
Bioinformatics

Technology Outlook (Revenue in Million USD; 2017-2027)

Sequencing by Synthesis (SBS)
Ion Semiconductor Sequencing
Single-molecule Real-time Sequencing (SMRT)
Nanopore Sequencing
Other Technologies

Application Outlook (Revenue in Million USD; 2017-2027)

Diagnostics
Cancer Diagnostics
Infectious Disease Diagnostics
Reproductive Health Diagnostics
Other Diagnostic Applications
Drug Discovery
Agricultural and Animal Research
Other Applications

Geographic Segment Covered in the Report:

The Next Generation Sequencing report provides information about the market area, which is further subdivided into sub-regions and countries/regions. In addition to the market share in each country and sub-region, this chapter of this report also contains information on profit opportunities. This chapter of the report mentions the market share and growth rate of each region, country, and sub-region during the estimated period.

• North America (the USA and Canada)
• Europe (UK, Germany, France, and the rest of Europe)
• Asia Pacific (China, Japan, India, and the rest of the Asia Pacific region)
• Latin America (Brazil, Mexico, and the rest of Latin America)
• the Middle East and Africa (GCC and the rest of the Middle East and Africa)

Browse Full Report Description with Research Methodology, Table of Content, and Infographics @ https://www.reportsanddata.com/report-detail/next-generation-sequencing-market

Key market aspects are illuminated in the report:

Executive Summary: It covers a summary of the most vital studies, the Global Next Generation Sequencing market increasing rate, modest circumstances, market trends, drivers and problems as well as macroscopic pointers.

Study Analysis: Covers major companies, vital market segments, the scope of the products offered in the Global Next Generation Sequencing market, the years measured, and the study points.

Company Profile: Each Firm well-defined in this segment is screened based on a products, value, SWOT analysis, their ability and other significant features.

Manufacture by Region: This Global Next Generation Sequencing report offers data on imports and exports, sales, production and key companies in all studied regional markets.

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/1868

Thank you for reading the report. Kindly note that we also offer customized reports according to the client's requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.

Explore More Industry Research by Reports and Data:

Female Infertility Market @ https://www.biospace.com/article/female-infertility-market-is-set-to-develop-new-growth-story-by-2030-reports-and-data/

Cholestasis Pruritus Treatment Market @ https://www.biospace.com/article/cholestasis-pruritus-treatment-market-is-likely-to-increase-at-a-significantly-high-cagr-by-2030-reports-and-data/

Charcot Marie Tooth Disease Market @ https://www.biospace.com/article/charcot-marie-tooth-disease-market-to-witness-a-discerning-growth-between-2022-2030-reports-and-data/

Bladder Pain Treatment Market @ https://www.biospace.com/article/bladder-pain-treatment-market-size-and-trends-shows-a-rapid-growth-by-2030-reports-and-data/

Contact Us:

John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.